Echavez, Baby Boy .

HRN: 27-51-21  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2025
AMPICILLIN 500MG (VIAL)
07/21/2025
07/28/2025
IV
150
Q12
Live Term Male Neonate Delivered Cephalic Via NSVD AS 7,9 BW 3000grams BS 40 Weeks, AGA; Thickly MSAF
Checking Initial Appropriateness 
07/21/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/21/2025
07/28/2025
IV
45
24H
Live Term Male Neonate Delivered Cephalic Via NSVD AS 7,9 BW 3000grams BS 40 Weeks, AGA; Thickly MSAF
Checking Initial Appropriateness 
07/21/2025
AMPICILLIN 250MG (VIAL)
07/21/2025
07/27/2025
IV
150mg
Q12h
PSNB
Waiting Final Action 
07/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/21/2025
07/27/2025
IV
45mg
OD
PSNB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: